Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127271471 | 12727147 | 1 | I | 20160824 | 20160909 | 20160909 | EXP | BR-CIPLA LTD.-2016BR17840 | CIPLA | 0.00 | Y | 0.00000 | 20160909 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127271471 | 12727147 | 1 | PS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | 1 MG/KG/HR | U | U | 0 | 1 | MG/KG | ||||||
| 127271471 | 12727147 | 2 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | 2 MG/KG/HR | U | U | 0 | 2 | MG/KG | ||||||
| 127271471 | 12727147 | 3 | SS | Lopinavir/Ritonavir | LOPINAVIRRITONAVIR | 1 | Oral | 1000 MG/DAY | U | U | 0 | 1000 | MG | ||||||
| 127271471 | 12727147 | 4 | SS | Lamivudine/Tenofovir | LAMIVUDINETENOFOVIR | 1 | Oral | 600 MG/DAY | U | U | 0 | 600 | MG | TABLET | |||||
| 127271471 | 12727147 | 5 | SS | Trimethoprim/Sulfamethoxazole | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK, PRIOR CONCEPTION | U | U | 0 | ||||||||
| 127271471 | 12727147 | 6 | SS | Trimethoprim/Sulfamethoxazole | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK, TRIMESTER 1, 2 AND 3 | U | U | 0 | ||||||||
| 127271471 | 12727147 | 7 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | UNK, TRIMESTER 3 | U | U | 0 | ||||||||
| 127271471 | 12727147 | 8 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | Unknown | UNK, TRIMESTER 3 | U | U | 0 | ||||||||
| 127271471 | 12727147 | 9 | SS | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | UNK, TRIMESTER 3 | U | U | 0 | ||||||||
| 127271471 | 12727147 | 10 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | UNK, TRIMESTER 1, 2 AND 3 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127271471 | 12727147 | 1 | HIV infection |
| 127271471 | 12727147 | 3 | HIV infection |
| 127271471 | 12727147 | 4 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127271471 | 12727147 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127271471 | 12727147 | Exposure during pregnancy | |
| 127271471 | 12727147 | Flavivirus infection | |
| 127271471 | 12727147 | Vaginal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127271471 | 12727147 | 1 | 20160816 | 20160816 | 0 | |
| 127271471 | 12727147 | 2 | 20160816 | 20160816 | 0 | |
| 127271471 | 12727147 | 3 | 20150505 | 0 | ||
| 127271471 | 12727147 | 4 | 20150505 | 0 |